speb/financial-data huggingface dataset:
EMCURE.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items: 0.00
EMCURE.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 0.00
EMCURE.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: 19194940000.00
EMCURE.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 10456100000.00
EMCURE.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 23634780000.00
EMCURE.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 189589638.00
EMCURE.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 12.16
EMCURE.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 9624300000.00
EMCURE.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 1046800000.00
EMCURE.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 1046800000.00
EMCURE.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 189589638.00
EMCURE.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 12.16
EMCURE.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 2305410000.00
EMCURE.NS income_statement (quarterly, 2025-12-31) — EBIT: 3517670000.00
EMCURE.NS income_statement (quarterly, 2025-12-31) — EBITDA: 4564470000.00
EMCURE.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 14010480000.00
EMCURE.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 379750000.00
EMCURE.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 379750000.00
EMCURE.NS income_statement (quarterly, 2025-12-31) — Minority Interests: -8290000.00
EMCURE.NS income_statement (quarterly, 2025-12-31) — Net Income: 2305410000.00
EMCURE.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 2305410000.00
EMCURE.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 2313700000.00
EMCURE.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 2305410000.00
EMCURE.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 2305410000.00
EMCURE.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 2313700000.00
EMCURE.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -379750000.00
EMCURE.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -379750000.00
EMCURE.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 4945970000.00
EMCURE.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 2586703516.09
EMCURE.NS income_statement (quarterly, 2025-12-31) — Operating Income: 3554380000.00
EMCURE.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 23634780000.00
EMCURE.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 18530000.00
EMCURE.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 5536010000.00
EMCURE.NS income_statement (quarterly, 2025-12-31) — Other Special Charges: 381500000.00
EMCURE.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
EMCURE.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 3137920000.00
EMCURE.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 9624300000.00
EMCURE.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 1046800000.00
EMCURE.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: -381500000.00
EMCURE.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -100206483.91
EMCURE.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 824220000.00
EMCURE.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.26
EMCURE.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 20080400000.00
EMCURE.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: -381500000.00
EMCURE.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -381500000.00
EMCURE.NS income_statement (annual, 2026-03-31) — +Operating Expense: 41729170000.00
EMCURE.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 10874060000.00
EMCURE.NS income_statement (annual, 2026-03-31) — +Total Revenue: 92035400000.00
EMCURE.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 24697030000.00
EMCURE.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 18077660000.00
EMCURE.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 18077660000.00
EMCURE.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 25626640000.00
EMCURE.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 25626640000.00
EMCURE.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 609420000.00
EMCURE.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 609420000.00
EMCURE.NS income_statement (annual, 2026-03-31) — Basic Average Shares: 189534755.00
EMCURE.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 189566199.00
EMCURE.NS income_statement (annual, 2026-03-31) — Basic EPS: 48.77
EMCURE.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 12.84
EMCURE.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: -143110000.00
EMCURE.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -5476870000.00
EMCURE.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 3171580000.00
EMCURE.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 3171580000.00
EMCURE.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 1895900000.00
EMCURE.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 1895900000.00
EMCURE.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 1366580000.00
EMCURE.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 1366580000.00
EMCURE.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 2162590000.00
EMCURE.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 2162590000.00
EMCURE.NS cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -568530000.00
EMCURE.NS cash_flow (annual, 2026-03-31) — Change In Inventory: -3838420000.00
EMCURE.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: -1036850000.00
EMCURE.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: 937250000.00
EMCURE.NS cash_flow (annual, 2026-03-31) — Change In Payable: 2765300000.00
EMCURE.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -4260590000.00
EMCURE.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -5301340000.00
EMCURE.NS cash_flow (annual, 2026-03-31) — Changes In Cash: 939210000.00
EMCURE.NS balance_sheet (annual, 2026-03-31) — Common Stock: 1895900000.00
EMCURE.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 1895900000.00
EMCURE.NS cash_flow (annual, 2026-03-31) — Common Stock Dividend Paid: -568530000.00
EMCURE.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 49500320000.00
EMCURE.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 49500320000.00
EMCURE.NS cash_flow (annual, 2026-03-31) — Common Stock Issuance: 66460000.00
EMCURE.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 1720570000.00
EMCURE.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 1720570000.00
EMCURE.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 36570620000.00
EMCURE.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 10030900000.00
EMCURE.NS balance_sheet (annual, 2026-03-31) — Current Assets: 56121030000.00
EMCURE.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 56121030000.00
EMCURE.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 548780000.00
EMCURE.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 548780000.00
EMCURE.NS balance_sheet (annual, 2026-03-31) — Current Debt: 9518720000.00
EMCURE.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 9518720000.00
EMCURE.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 10067500000.00
EMCURE.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 10067500000.00
EMCURE.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 39122410000.00
EMCURE.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 39122410000.00
EMCURE.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 722640000.00
EMCURE.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 722640000.00
EMCURE.NS cash_flow (annual, 2026-03-31) — Depreciation: 4150460000.00
EMCURE.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 4150460000.00
EMCURE.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 4150460000.00
EMCURE.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 1062670000.00
EMCURE.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 4150460000.00
EMCURE.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 1062670000.00
EMCURE.NS income_statement (annual, 2026-03-31) — Diluted Average Shares: 189534755.00
EMCURE.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 189566199.00
EMCURE.NS income_statement (annual, 2026-03-31) — Diluted EPS: 48.77
EMCURE.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 12.84
EMCURE.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 9243610000.00
EMCURE.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 2434030000.00
EMCURE.NS income_statement (annual, 2026-03-31) — EBIT: 14308160000.00
EMCURE.NS income_statement (quarterly, 2026-03-31) — EBIT: 3875770000.00
EMCURE.NS income_statement (annual, 2026-03-31) — EBITDA: 18458620000.00
EMCURE.NS income_statement (quarterly, 2026-03-31) — EBITDA: 4938440000.00
EMCURE.NS cash_flow (annual, 2026-03-31) — Effect Of Exchange Rate Changes: 181550000.00
EMCURE.NS cash_flow (annual, 2026-03-31) — End Cash Position: 977650000.00
EMCURE.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: 3434310000.00
EMCURE.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: 3958580000.00
EMCURE.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: -15240000.00
EMCURE.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: 2340000.00
EMCURE.NS balance_sheet (annual, 2026-03-31) — Goodwill: 4142590000.00
EMCURE.NS balance_sheet (quarterly, 2026-03-31) — Goodwill: 4142590000.00
EMCURE.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 11011000000.00
EMCURE.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 11011000000.00
EMCURE.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 24908220000.00
EMCURE.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 24908220000.00
EMCURE.NS income_statement (annual, 2026-03-31) — Gross Profit: 55464780000.00
EMCURE.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 14666130000.00
EMCURE.NS income_statement (annual, 2026-03-31) — Interest Expense: 1436730000.00
EMCURE.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 464010000.00
EMCURE.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 1436730000.00
EMCURE.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 464010000.00
EMCURE.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -947890000.00
EMCURE.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 17720000.00
EMCURE.NS balance_sheet (annual, 2026-03-31) — Inventory: 23978740000.00
EMCURE.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 23978740000.00
EMCURE.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 61541150000.00
EMCURE.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 61541150000.00
EMCURE.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -11930550000.00
EMCURE.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 609420000.00
EMCURE.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 609420000.00
EMCURE.NS cash_flow (annual, 2026-03-31) — Issuance Of Capital Stock: 66460000.00
EMCURE.NS cash_flow (annual, 2026-03-31) — Issuance Of Debt: 6802730000.00
EMCURE.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 2622800000.00
EMCURE.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 2622800000.00
EMCURE.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 2522110000.00
EMCURE.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 2522110000.00
EMCURE.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 5144910000.00
EMCURE.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 5144910000.00
EMCURE.NS cash_flow (annual, 2026-03-31) — Long Term Debt Issuance: 2500000000.00
EMCURE.NS cash_flow (annual, 2026-03-31) — Long Term Debt Payments: -1291550000.00
EMCURE.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 426010000.00
EMCURE.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 426010000.00
EMCURE.NS balance_sheet (annual, 2026-03-31) — Minority Interest: 266410000.00
EMCURE.NS balance_sheet (quarterly, 2026-03-31) — Minority Interest: 266410000.00
EMCURE.NS income_statement (annual, 2026-03-31) — Minority Interests: -169080000.00
EMCURE.NS income_statement (quarterly, 2026-03-31) — Minority Interests: -3330000.00
EMCURE.NS cash_flow (annual, 2026-03-31) — Net Business Purchase And Sale: -7248940000.00
EMCURE.NS cash_flow (annual, 2026-03-31) — Net Common Stock Issuance: 66460000.00
EMCURE.NS balance_sheet (annual, 2026-03-31) — Net Debt: 10674250000.00
EMCURE.NS balance_sheet (quarterly, 2026-03-31) — Net Debt: 10674250000.00
EMCURE.NS cash_flow (annual, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: -464330000.00
EMCURE.NS income_statement (annual, 2026-03-31) — Net Income: 9243610000.00
EMCURE.NS income_statement (quarterly, 2026-03-31) — Net Income: 2434030000.00
EMCURE.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 9243610000.00
EMCURE.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 2434030000.00
EMCURE.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 9412690000.00
EMCURE.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 2437360000.00
EMCURE.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 9243610000.00
EMCURE.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 2434030000.00
EMCURE.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 9243610000.00
EMCURE.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 2434030000.00
EMCURE.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 12871430000.00
EMCURE.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 9412690000.00
EMCURE.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 2437360000.00
EMCURE.NS cash_flow (annual, 2026-03-31) — Net Intangibles Purchase And Sale: -1871270000.00
EMCURE.NS income_statement (annual, 2026-03-31) — Net Interest Income: -1436730000.00
EMCURE.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -464010000.00
EMCURE.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: 734940000.00
EMCURE.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: 5511180000.00
EMCURE.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: 1208450000.00
EMCURE.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -1436730000.00
EMCURE.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -464010000.00
EMCURE.NS balance_sheet (annual, 2026-03-31) — Net PPE: 24908220000.00
EMCURE.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 24908220000.00
EMCURE.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -3563000000.00
EMCURE.NS cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: 4302730000.00
EMCURE.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 38489320000.00
EMCURE.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 38489320000.00
EMCURE.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Assets: 1393730000.00
EMCURE.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 1393730000.00
EMCURE.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 980000000.00
EMCURE.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 980000000.00
EMCURE.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 19200750000.00
EMCURE.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 5264070000.00
EMCURE.NS income_statement (annual, 2026-03-31) — Normalized Income: 9786318901.01
EMCURE.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 2666659943.72
EMCURE.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 9435450000.00
EMCURE.NS income_statement (annual, 2026-03-31) — Operating Income: 13735610000.00
EMCURE.NS income_statement (quarterly, 2026-03-31) — Operating Income: 3792070000.00
EMCURE.NS income_statement (annual, 2026-03-31) — Operating Revenue: 92035400000.00
EMCURE.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 24697030000.00
EMCURE.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 189589547.00
EMCURE.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 189589547.00
EMCURE.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 4353060000.00
EMCURE.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 4353060000.00
EMCURE.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 965290000.00
EMCURE.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 965290000.00
EMCURE.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 47604420000.00
EMCURE.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 47604420000.00
EMCURE.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 6868410000.00
EMCURE.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 6868410000.00
EMCURE.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: 1844640000.00
EMCURE.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 1112140000.00
EMCURE.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 1112140000.00
EMCURE.NS balance_sheet (annual, 2026-03-31) — Other Non Current Liabilities: 73040000.00
EMCURE.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 73040000.00
EMCURE.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 126640000.00
EMCURE.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 39920000.00
EMCURE.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 22056730000.00
EMCURE.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 5943620000.00
EMCURE.NS balance_sheet (annual, 2026-03-31) — Other Properties: 23187650000.00
EMCURE.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 23187650000.00
EMCURE.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 796010000.00
EMCURE.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 796010000.00
EMCURE.NS income_statement (annual, 2026-03-31) — Other Special Charges: 313490000.00
EMCURE.NS income_statement (quarterly, 2026-03-31) — Other Special Charges: -103010000.00
EMCURE.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
EMCURE.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
EMCURE.NS balance_sheet (annual, 2026-03-31) — Payables: 19507620000.00
EMCURE.NS balance_sheet (quarterly, 2026-03-31) — Payables: 19507620000.00
EMCURE.NS income_statement (annual, 2026-03-31) — Pretax Income: 12871430000.00
EMCURE.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 3411760000.00
EMCURE.NS cash_flow (annual, 2026-03-31) — Purchase Of Business: -7248940000.00
EMCURE.NS cash_flow (annual, 2026-03-31) — Purchase Of Intangibles: -1871270000.00
EMCURE.NS cash_flow (annual, 2026-03-31) — Purchase Of Investment: -5839710000.00
EMCURE.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -3605600000.00
EMCURE.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 36570620000.00
EMCURE.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 10030900000.00
EMCURE.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 4150460000.00
EMCURE.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 1062670000.00
EMCURE.NS cash_flow (annual, 2026-03-31) — Repayment Of Debt: -1291550000.00
EMCURE.NS income_statement (annual, 2026-03-31) — Restructuring And Mergern Acquisition: 428640000.00
EMCURE.NS income_statement (quarterly, 2026-03-31) — Restructuring And Mergern Acquisition: 428640000.00
EMCURE.NS cash_flow (annual, 2026-03-31) — Sale Of Investment: 6574650000.00
EMCURE.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 42600000.00
EMCURE.NS balance_sheet (annual, 2026-03-31) — Share Issued: 189589547.00
EMCURE.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 189589547.00
EMCURE.NS cash_flow (annual, 2026-03-31) — Short Term Debt Issuance: 4302730000.00
EMCURE.NS income_statement (annual, 2026-03-31) — Special Income Charges: -742130000.00
EMCURE.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: -325630000.00
EMCURE.NS cash_flow (annual, 2026-03-31) — Stock Based Compensation: 28290000.00
EMCURE.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 49500320000.00
EMCURE.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 49500320000.00
EMCURE.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 38489320000.00
EMCURE.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 38489320000.00
EMCURE.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: -199421098.99
EMCURE.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -93000056.28
EMCURE.NS income_statement (annual, 2026-03-31) — Tax Provision: 3458740000.00
EMCURE.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 974400000.00
EMCURE.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.27
EMCURE.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.29
EMCURE.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -3680800000.00
EMCURE.NS balance_sheet (annual, 2026-03-31) — Total Assets: 96124810000.00
EMCURE.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 96124810000.00
EMCURE.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 52022430000.00
EMCURE.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 52022430000.00
EMCURE.NS balance_sheet (annual, 2026-03-31) — Total Debt: 15212410000.00
EMCURE.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 15212410000.00
EMCURE.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 49766730000.00
EMCURE.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 49766730000.00
EMCURE.NS income_statement (annual, 2026-03-31) — Total Expenses: 78299790000.00
EMCURE.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 20904960000.00
EMCURE.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 46358080000.00
EMCURE.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 46358080000.00
EMCURE.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 40003780000.00
EMCURE.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 40003780000.00
EMCURE.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 7235670000.00
EMCURE.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 7235670000.00
EMCURE.NS balance_sheet (annual, 2026-03-31) — Total Tax Payable: 1429960000.00
EMCURE.NS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 1429960000.00
EMCURE.NS income_statement (annual, 2026-03-31) — Total Unusual Items: -742130000.00
EMCURE.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: -325630000.00
EMCURE.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: -742130000.00
EMCURE.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -325630000.00
EMCURE.NS balance_sheet (annual, 2026-03-31) — Treasury Shares Number: 0.00
EMCURE.NS balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 0.00
EMCURE.NS balance_sheet (annual, 2026-03-31) — Working Capital: 16998620000.00
EMCURE.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 16998620000.00
EMD income_statement (annual, 2021-12-31) — Basic Average Shares: 61041380.00
EMD income_statement (annual, 2021-12-31) — Basic EPS: -0.59
EMD cash_flow (annual, 2021-12-31) — Change In Other Current Assets: -584847.00
EMD balance_sheet (annual, 2021-12-31) — Derivative Product Liabilities: 736840.00
EMD income_statement (annual, 2021-12-31) — Diluted Average Shares: 61041380.00
EMD income_statement (annual, 2021-12-31) — Diluted EPS: -0.59
EMD balance_sheet (annual, 2021-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 2544473.00
EMD cash_flow (annual, 2021-12-31) — Long Term Debt Payments: -21687248.00
EMD cash_flow (annual, 2021-12-31) — Repayment Of Debt: -21687248.00
EMD income_statement (annual, 2022-12-31) — +Operating Expense: 1211406.00
EMD income_statement (annual, 2022-12-31) — +Total Revenue: -148397560.00
EMD balance_sheet (annual, 2022-12-31) — Accounts Payable: 3441641.00
EMD balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 1016516506.00
EMD balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 835837145.00
EMD income_statement (annual, 2022-12-31) — Basic Average Shares: 60570432.00
EMD income_statement (annual, 2022-12-31) — Basic EPS: -2.47
EMD cash_flow (annual, 2022-12-31) — Beginning Cash Position: 5738162.00
EMD balance_sheet (annual, 2022-12-31) — Capital Stock: 60246.00
EMD balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 3109048.00
EMD balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Federal Funds Sold: 5490748.00
EMD cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -60943836.00
EMD balance_sheet (annual, 2022-12-31) — Cash Financial: 3109048.00
EMD cash_flow (annual, 2022-12-31) — Change In Accrued Expense: -15166.00
EMD cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -149509.00
EMD cash_flow (annual, 2022-12-31) — Change In Payable: 2778323.00
EMD cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -1213813.00
EMD cash_flow (annual, 2022-12-31) — Change In Receivables: 3566545.00
EMD cash_flow (annual, 2022-12-31) — Change In Working Capital: 4966380.00
EMD cash_flow (annual, 2022-12-31) — Changes In Cash: -247414.00
EMD balance_sheet (annual, 2022-12-31) — Common Stock: 60246.00
EMD cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -60943836.00
EMD balance_sheet (annual, 2022-12-31) — Common Stock Equity: 616807549.00
EMD cash_flow (annual, 2022-12-31) — Common Stock Payments: -5175727.00
EMD balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 1158418.00
EMD income_statement (annual, 2022-12-31) — Diluted Average Shares: 60570432.00
EMD income_statement (annual, 2022-12-31) — Diluted EPS: -2.47
EMD income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -149608966.00
EMD cash_flow (annual, 2022-12-31) — End Cash Position: 5490748.00
EMD balance_sheet (annual, 2022-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 636636.00
EMD cash_flow (annual, 2022-12-31) — Financing Cash Flow: -171103626.00
EMD cash_flow (annual, 2022-12-31) — Free Cash Flow: 170856212.00
EMD cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 320244905.00
EMD income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -65445907.00
EMD income_statement (annual, 2022-12-31) — General And Administrative Expense: 792514.00
EMD income_statement (annual, 2022-12-31) — Interest Expense: 6213959.00
EMD income_statement (annual, 2022-12-31) — Interest Income: 60737809.00
EMD balance_sheet (annual, 2022-12-31) — Invested Capital: 851807549.00
EMD balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 837272247.00
EMD balance_sheet (annual, 2022-12-31) — Investments And Advances: 837272247.00
EMD balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 235000000.00
EMD cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -104984063.00
EMD cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -5175727.00
EMD balance_sheet (annual, 2022-12-31) — Net Debt: 231890952.00
EMD income_statement (annual, 2022-12-31) — Net Income: -149608966.00
EMD income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -149608966.00
EMD income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -149608966.00
EMD income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -149608966.00
EMD income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -149608966.00
EMD cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -149608966.00
EMD income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -149608966.00
EMD income_statement (annual, 2022-12-31) — Net Interest Income: 54523850.00
EMD cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -104984063.00
EMD cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -104984063.00
EMD cash_flow (annual, 2022-12-31) — Net Other Financing Charges: 0.00
EMD balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 616807549.00
EMD income_statement (annual, 2022-12-31) — Normalized Income: -149608966.00
EMD cash_flow (annual, 2022-12-31) — Operating Cash Flow: 170856212.00
EMD income_statement (annual, 2022-12-31) — Operating Revenue: -148397560.00
EMD balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 60246012.00
EMD cash_flow (annual, 2022-12-31) — Other Non Cash Items: -4746107.00
EMD income_statement (annual, 2022-12-31) — Other Operating Expenses: 418892.00
EMD balance_sheet (annual, 2022-12-31) — Other Payable: 794636.00
EMD balance_sheet (annual, 2022-12-31) — Payables: 4254264.00
EMD balance_sheet (annual, 2022-12-31) — Prepaid Assets: 3646.00
EMD income_statement (annual, 2022-12-31) — Pretax Income: -149608966.00
EMD balance_sheet (annual, 2022-12-31) — Receivables: 14630739.00
EMD cash_flow (annual, 2022-12-31) — Repayment Of Debt: -104984063.00
EMD cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -5175727.00
EMD balance_sheet (annual, 2022-12-31) — Retained Earnings: -399769203.00
EMD income_statement (annual, 2022-12-31) — Selling General And Administration: 792514.00
EMD balance_sheet (annual, 2022-12-31) — Share Issued: 60246012.00
EMD balance_sheet (annual, 2022-12-31) — Stockholders Equity: 616807549.00
EMD balance_sheet (annual, 2022-12-31) — Tangible Book Value: 616807549.00
EMD income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
EMD income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
EMD balance_sheet (annual, 2022-12-31) — Total Assets: 857397380.00
EMD balance_sheet (annual, 2022-12-31) — Total Capitalization: 851807549.00
EMD balance_sheet (annual, 2022-12-31) — Total Debt: 235000000.00
EMD balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 616807549.00
EMD balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 240589831.00
EMD balance_sheet (annual, 2022-12-31) — Total Tax Payable: 17987.00
EMD income_statement (annual, 2023-12-31) — +Operating Expense: 1153987.00
EMD income_statement (annual, 2023-12-31) — +Total Revenue: 72556413.00
EMD balance_sheet (annual, 2023-12-31) — Accounts Payable: 1477538.00
EMD balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 984509527.00
EMD balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 854660024.00
EMD income_statement (annual, 2023-12-31) — Basic Average Shares: 59010269.00
EMD income_statement (annual, 2023-12-31) — Basic EPS: 1.21
EMD cash_flow (annual, 2023-12-31) — Beginning Cash Position: 5490748.00
EMD balance_sheet (annual, 2023-12-31) — Capital Stock: 58444.00
EMD balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 241.00
EMD balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Federal Funds Sold: 882424.00
EMD cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -54836948.00
EMD balance_sheet (annual, 2023-12-31) — Cash Financial: 241.00
EMD cash_flow (annual, 2023-12-31) — Change In Accrued Expense: 163245.00
EMD cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -140000.00
EMD cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -167293.00
EMD cash_flow (annual, 2023-12-31) — Change In Payable: -2198151.00
EMD cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -57.00
EMD cash_flow (annual, 2023-12-31) — Change In Receivables: -1441339.00
EMD cash_flow (annual, 2023-12-31) — Change In Working Capital: -3783595.00
EMD cash_flow (annual, 2023-12-31) — Changes In Cash: -4608324.00
EMD balance_sheet (annual, 2023-12-31) — Common Stock: 58444.00
EMD cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -54836948.00
EMD balance_sheet (annual, 2023-12-31) — Common Stock Equity: 617562033.00
EMD cash_flow (annual, 2023-12-31) — Common Stock Payments: -15810994.00
EMD balance_sheet (annual, 2023-12-31) — Derivative Product Liabilities: 2360727.00
EMD income_statement (annual, 2023-12-31) — Diluted Average Shares: 59010269.00
EMD income_statement (annual, 2023-12-31) — Diluted EPS: 1.21
EMD income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 71402426.00
EMD cash_flow (annual, 2023-12-31) — End Cash Position: 882424.00
EMD cash_flow (annual, 2023-12-31) — Financing Cash Flow: -55466377.00
EMD cash_flow (annual, 2023-12-31) — Free Cash Flow: 50858053.00
EMD cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: -6203430.00
EMD income_statement (annual, 2023-12-31) — Gain On Sale Of Security: -51343034.00
EMD income_statement (annual, 2023-12-31) — General And Administrative Expense: 657675.00
EMD income_statement (annual, 2023-12-31) — Interest Expense: 14361478.00
EMD income_statement (annual, 2023-12-31) — Interest Income: 65389058.00
EMD balance_sheet (annual, 2023-12-31) — Invested Capital: 867562033.00
EMD balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 855384640.00
EMD balance_sheet (annual, 2023-12-31) — Investments And Advances: 855384640.00
EMD cash_flow (annual, 2023-12-31) — Issuance Of Debt: 15000000.00
EMD balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 250000000.00
EMD cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 15000000.00
EMD cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -15810994.00
EMD balance_sheet (annual, 2023-12-31) — Net Debt: 249999759.00
EMD income_statement (annual, 2023-12-31) — Net Income: 71402426.00
EMD income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 71402426.00
EMD income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 71402426.00
EMD income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 71402426.00
EMD income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 71402426.00
EMD cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 71402426.00
EMD income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 71402426.00
EMD income_statement (annual, 2023-12-31) — Net Interest Income: 51027580.00
EMD cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 15000000.00
EMD cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 15000000.00
EMD cash_flow (annual, 2023-12-31) — Net Other Financing Charges: 181565.00
EMD balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 617562033.00
EMD income_statement (annual, 2023-12-31) — Normalized Income: 71402426.00
EMD cash_flow (annual, 2023-12-31) — Operating Cash Flow: 50858053.00
EMD income_statement (annual, 2023-12-31) — Operating Revenue: 72556413.00
EMD balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 58443565.00
EMD cash_flow (annual, 2023-12-31) — Other Non Cash Items: -10557348.00
EMD income_statement (annual, 2023-12-31) — Other Operating Expenses: 496312.00
EMD balance_sheet (annual, 2023-12-31) — Other Payable: 647153.00
EMD balance_sheet (annual, 2023-12-31) — Payables: 2124691.00
EMD balance_sheet (annual, 2023-12-31) — Prepaid Assets: 3703.00
EMD income_statement (annual, 2023-12-31) — Pretax Income: 71402426.00
EMD balance_sheet (annual, 2023-12-31) — Receivables: 16072078.00
EMD cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -15810994.00
EMD balance_sheet (annual, 2023-12-31) — Retained Earnings: -367005938.00
EMD income_statement (annual, 2023-12-31) — Selling General And Administration: 657675.00
EMD balance_sheet (annual, 2023-12-31) — Share Issued: 58443565.00
EMD balance_sheet (annual, 2023-12-31) — Stockholders Equity: 617562033.00
EMD balance_sheet (annual, 2023-12-31) — Tangible Book Value: 617562033.00
EMD income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
EMD income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.21
EMD balance_sheet (annual, 2023-12-31) — Total Assets: 872342845.00
EMD balance_sheet (annual, 2023-12-31) — Total Capitalization: 867562033.00
EMD balance_sheet (annual, 2023-12-31) — Total Debt: 250000000.00
EMD balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 617562033.00
EMD balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 254780812.00
EMD income_statement (annual, 2024-12-31) — +Operating Expense: 1161439.00
EMD income_statement (annual, 2024-12-31) — +Total Revenue: 62709882.00
EMD balance_sheet (annual, 2024-12-31) — Accounts Payable: 918187.00
EMD balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 918187.00
EMD balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 971403176.00
EMD balance_sheet (quarterly, 2024-12-31) — Additional Paid In Capital: 971403176.00
EMD balance_sheet (annual, 2024-12-31) — Available For Sale Securities: 801256023.00
EMD balance_sheet (quarterly, 2024-12-31) — Available For Sale Securities: 801256023.00
EMD income_statement (annual, 2024-12-31) — Basic Average Shares: 58064569.00
EMD income_statement (annual, 2024-12-31) — Basic EPS: 1.06
EMD cash_flow (annual, 2024-12-31) — Beginning Cash Position: 882424.00
EMD balance_sheet (annual, 2024-12-31) — Capital Stock: 58130.00
EMD balance_sheet (quarterly, 2024-12-31) — Capital Stock: 58130.00
EMD balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 189.00
EMD balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 189.00
EMD balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Federal Funds Sold: 500505.00
EMD balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Federal Funds Sold: 500505.00
EMD cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -59398218.00
EMD balance_sheet (annual, 2024-12-31) — Cash Financial: 189.00
EMD balance_sheet (quarterly, 2024-12-31) — Cash Financial: 189.00
EMD cash_flow (annual, 2024-12-31) — Change In Accrued Expense: -68968.00
EMD cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: 0.00
EMD cash_flow (annual, 2024-12-31) — Change In Payable: -413866.00
EMD cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 1141.00
EMD cash_flow (annual, 2024-12-31) — Change In Receivables: 1407896.00
EMD cash_flow (annual, 2024-12-31) — Change In Working Capital: 926203.00
EMD cash_flow (annual, 2024-12-31) — Changes In Cash: -381919.00
EMD balance_sheet (annual, 2024-12-31) — Common Stock: 58130.00
EMD balance_sheet (quarterly, 2024-12-31) — Common Stock: 58130.00
EMD cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -59398218.00
EMD balance_sheet (annual, 2024-12-31) — Common Stock Equity: 616618400.00
EMD balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: 616618400.00
EMD cash_flow (annual, 2024-12-31) — Common Stock Payments: -3093858.00
EMD income_statement (annual, 2024-12-31) — Diluted Average Shares: 58064569.00
EMD income_statement (annual, 2024-12-31) — Diluted EPS: 1.06
EMD income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 61548443.00
EMD cash_flow (annual, 2024-12-31) — End Cash Position: 500505.00
EMD cash_flow (annual, 2024-12-31) — Financing Cash Flow: -112673641.00
EMD cash_flow (annual, 2024-12-31) — Free Cash Flow: 112291722.00
EMD cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 61916688.00
EMD income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -27951702.00
EMD income_statement (annual, 2024-12-31) — General And Administrative Expense: 967613.00
EMD income_statement (annual, 2024-12-31) — Interest Expense: 13685472.00
EMD income_statement (annual, 2024-12-31) — Interest Income: 69641065.00
EMD balance_sheet (annual, 2024-12-31) — Invested Capital: 816618400.00
EMD balance_sheet (quarterly, 2024-12-31) — Invested Capital: 816618400.00
EMD balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 803206837.00
EMD balance_sheet (quarterly, 2024-12-31) — Investmentin Financial Assets: 803206837.00
EMD balance_sheet (annual, 2024-12-31) — Investments And Advances: 803206837.00
EMD balance_sheet (quarterly, 2024-12-31) — Investments And Advances: 803206837.00
EMD balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 200000000.00
EMD balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 200000000.00
EMD cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -50000000.00
EMD cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -3093858.00
EMD balance_sheet (annual, 2024-12-31) — Net Debt: 199999811.00
EMD balance_sheet (quarterly, 2024-12-31) — Net Debt: 199999811.00
EMD income_statement (annual, 2024-12-31) — Net Income: 61548443.00
EMD income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 61548443.00
EMD income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 61548443.00
EMD income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 61548443.00
EMD income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 61548443.00
EMD cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 61548443.00
EMD income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 61548443.00
EMD income_statement (annual, 2024-12-31) — Net Interest Income: 55955593.00
EMD cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -50000000.00
EMD cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -50000000.00
EMD cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -181565.00
EMD balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 616618400.00
EMD balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: 616618400.00
EMD income_statement (annual, 2024-12-31) — Normalized Income: 61548443.00
EMD cash_flow (annual, 2024-12-31) — Operating Cash Flow: 112291722.00
EMD income_statement (annual, 2024-12-31) — Operating Revenue: 62709882.00
EMD balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 58130443.00
EMD balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 58130443.00
EMD cash_flow (annual, 2024-12-31) — Other Non Cash Items: -12099612.00
EMD income_statement (annual, 2024-12-31) — Other Operating Expenses: 193826.00
EMD balance_sheet (annual, 2024-12-31) — Other Payable: 611073.00
EMD balance_sheet (quarterly, 2024-12-31) — Other Payable: 611073.00
EMD balance_sheet (annual, 2024-12-31) — Payables: 1529260.00
EMD balance_sheet (quarterly, 2024-12-31) — Payables: 1529260.00
EMD balance_sheet (annual, 2024-12-31) — Prepaid Assets: 2562.00
EMD balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 2562.00
EMD income_statement (annual, 2024-12-31) — Pretax Income: 61548443.00
EMD balance_sheet (annual, 2024-12-31) — Receivables: 14664182.00
EMD balance_sheet (quarterly, 2024-12-31) — Receivables: 14664182.00
EMD cash_flow (annual, 2024-12-31) — Repayment Of Debt: -50000000.00
EMD cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -3093858.00
EMD balance_sheet (annual, 2024-12-31) — Retained Earnings: -354842906.00
EMD balance_sheet (quarterly, 2024-12-31) — Retained Earnings: -354842906.00
EMD income_statement (annual, 2024-12-31) — Selling General And Administration: 967613.00
EMD balance_sheet (annual, 2024-12-31) — Share Issued: 58130443.00
EMD balance_sheet (quarterly, 2024-12-31) — Share Issued: 58130443.00
EMD balance_sheet (annual, 2024-12-31) — Stockholders Equity: 616618400.00
EMD balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 616618400.00
EMD balance_sheet (annual, 2024-12-31) — Tangible Book Value: 616618400.00
EMD balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: 616618400.00
EMD income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
EMD income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.21
EMD balance_sheet (annual, 2024-12-31) — Total Assets: 818374086.00
EMD balance_sheet (quarterly, 2024-12-31) — Total Assets: 818374086.00
EMD balance_sheet (annual, 2024-12-31) — Total Capitalization: 816618400.00
EMD balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 816618400.00
EMD balance_sheet (annual, 2024-12-31) — Total Debt: 200000000.00
EMD balance_sheet (quarterly, 2024-12-31) — Total Debt: 200000000.00
EMD balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 616618400.00
EMD balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 616618400.00
EMD balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 201755686.00
EMD balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 201755686.00
EMD balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 24726701.00
EMD balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 971403176.00
EMD balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 18553345.00
EMD balance_sheet (quarterly, 2025-06-30) — Capital Stock: 58130.00
EMD balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 3664034.00
EMD balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Federal Funds Sold: 4629001.00
EMD balance_sheet (quarterly, 2025-06-30) — Cash Financial: 3664034.00
EMD balance_sheet (quarterly, 2025-06-30) — Common Stock: 58130.00
EMD balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 622009442.00
EMD balance_sheet (quarterly, 2025-06-30) — Derivative Product Liabilities: 1272745.00
EMD balance_sheet (quarterly, 2025-06-30) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 825489954.00
EMD balance_sheet (quarterly, 2025-06-30) — Invested Capital: 852789356.00
EMD balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 844273682.00
EMD balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 844273682.00
EMD balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 230779914.00
EMD balance_sheet (quarterly, 2025-06-30) — Net Debt: 227115880.00
EMD balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 622009442.00
EMD balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 58130443.00
EMD balance_sheet (quarterly, 2025-06-30) — Other Payable: 683206.00
EMD balance_sheet (quarterly, 2025-06-30) — Payables: 25451565.00
EMD balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 14989.00
EMD balance_sheet (quarterly, 2025-06-30) — Receivables: 31193468.00
EMD balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -349451864.00
EMD balance_sheet (quarterly, 2025-06-30) — Share Issued: 58130443.00